1. Home
  2. TECH vs ENSG Comparison

TECH vs ENSG Comparison

Compare TECH & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$59.15

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Logo The Ensign Group Inc.

ENSG

The Ensign Group Inc.

HOLD

Current Price

$176.29

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
ENSG
Founded
1976
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
10.5B
IPO Year
1989
2007

Fundamental Metrics

Financial Performance
Metric
TECH
ENSG
Price
$59.15
$176.29
Analyst Decision
Strong Buy
Buy
Analyst Count
14
5
Target Price
$71.23
$196.40
AVG Volume (30 Days)
1.6M
346.4K
Earning Date
02-04-2026
02-04-2026
Dividend Yield
0.54%
0.15%
EPS Growth
N/A
35.03
EPS
0.49
5.59
Revenue
$1,216,732,000.00
$4,829,467,000.00
Revenue This Year
$2.33
$21.25
Revenue Next Year
$7.05
$12.54
P/E Ratio
$121.71
$31.55
Revenue Growth
3.85
17.55
52 Week Low
$46.01
$118.73
52 Week High
$79.28
$194.00

Technical Indicators

Market Signals
Indicator
TECH
ENSG
Relative Strength Index (RSI) 47.08 45.61
Support Level $56.84 $175.11
Resistance Level $59.64 $181.98
Average True Range (ATR) 1.57 3.21
MACD 0.04 0.05
Stochastic Oscillator 55.59 38.42

Price Performance

Historical Comparison
TECH
ENSG

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About ENSG The Ensign Group Inc.

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Share on Social Networks: